Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

539
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
539
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

484
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
484
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

583
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
583
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early referral of patients with suspected polymyalgia rheumatica - A systematic review.

Seminars in arthritis and rheumatism·2023
Same author

Association of ultrasound-confirmed axillary artery vasculitis and clinical outcomes in giant cell arteritis.

Seminars in arthritis and rheumatism·2022
Same author

A study on echocardiographic findings in hospitalized patients with connective tissue diseases.

Scandinavian journal of rheumatology·2021
Same author

[S2k guidelines: management of large-vessel vasculitis].

Zeitschrift fur Rheumatologie·2020
Same author

[S2k guidelines (executive summary): management of large-vessel vasculitis].

Zeitschrift fur Rheumatologie·2020
Same author

[Imaging diagnostics in large vessel vasculitis].

Zeitschrift fur Rheumatologie·2019

Related Experiment Video

Updated: Apr 28, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.5K

[Polymyalgia rheumatica in daily routine practice].

M Talke1, W A Schmidt

  • 1Orthopädie, Rheumatologie, Traumatologie, Praxis "Orthos", AnsbacherStr. 17-19, 10780, Berlin, Deutschland, martingelore@t-online.de.

Zeitschrift Fur Rheumatologie
|June 14, 2014
PubMed
Summary
This summary is machine-generated.

Polymyalgia rheumatica (PMR) is an inflammatory condition affecting individuals over 50, primarily impacting the shoulders and pelvis. Early diagnosis and appropriate glucocorticoid treatment are key for managing this painful disease.

More Related Videos

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.8K
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.5K
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.8K
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.7K

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Context:

  • Polymyalgia rheumatica (PMR) is a painful inflammatory condition predominantly affecting individuals over 50 years old, with a higher incidence in women.
  • The disease commonly involves the shoulder girdle and often the pelvic girdle, impacting mobility and quality of life.

Purpose:

  • To outline the definition, epidemiology, diagnostic challenges, and current treatment strategies for Polymyalgia Rheumatica (PMR).
  • To highlight the importance of accurate diagnosis, differentiating PMR from other musculoskeletal conditions, and the role of updated classification criteria.

Summary:

  • PMR affects Caucasians over 50, peaking at 72 years, with women affected twice as often as men.
  • Misdiagnosis is common; differential diagnosis includes various shoulder and rheumatic conditions. Elevated ESR and CRP, along with characteristic imaging findings, are crucial for diagnosis.
  • New EULAR/ACR classification criteria, incorporating ultrasound, improve diagnostic accuracy.
  • Glucocorticoids remain the primary treatment, with careful dose reduction protocols. Methotrexate may be used as an adjunct to reduce steroid dosage and minimize side effects.

Impact:

  • Improved diagnostic accuracy through updated criteria and imaging can lead to earlier and more effective treatment initiation.
  • Optimized glucocorticoid therapy and the potential use of methotrexate can help manage symptoms and reduce long-term treatment-related complications.
  • Enhanced understanding of PMR epidemiology and diagnostic pathways can inform public health strategies and clinical practice guidelines.